Clinical Trial Testing Services

In your quest to develop effective new therapies for cancer, our clinical trial testing services give you the necessary support to deliver results. We have a long history of success in the enumeration and characterization of rare cells, including Circulating Tumor Cells, Circulating Epithelial Cells, Circulating Melanoma Cells, progenitor cells and more. And Veridex CRS enables you to characterize those cells further, and get high value information at the gene, chromosome and protein levels. From preclinical to Phase 4 trials, we’re the partner you can rely on to move your research forward.